PEN News and Press, Penumbra Inc. From 05/07/24

2024-05-07 16:27:21 ET More on Penumbra Penumbra Q4: Solid Is Not Good Enough Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript Penumbra Q1 2024 Earnings Preview Penumbra cut to Hold at J.P. Morgan on first revenue miss Seeking Alpha’s Quan...

Penumbra, Inc. Reports First Quarter 2024 Financial Results PR Newswire ALAMEDA, Calif. , May 7, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter e...

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

2024-05-06 17:35:59 ET More on Penumbra Penumbra Q4: Solid Is Not Good Enough Penumbra, Inc. (PEN) Q4 2023 Earnings Call Transcript Penumbra cut to Hold at J.P. Morgan on first revenue miss Seeking Alpha’s Quant Rating on Penumbra Historical ea...

Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference PR Newswire ALAMEDA, Calif. , May 1, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the RBC Capital Markets Glob...

Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots PR Newswire Lightning Flash™ 2.0 features advanced computer assisted vacuum thrombectomy (CAVT) software, designed for increased efficiency and sensitivity to enha...

2024-04-13 20:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-04-09 16:49:42 ET Summary AngioDynamics has sold low-growth businesses, shifted to an outsourced manufacturing model, and refocused on cardiovascular and oncological care for potential growth. The recent approval of the AlphaVac F18 mechanical thrombectomy system for pulmonar...

Penumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024 PR Newswire ALAMEDA, Calif. , April 9, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial result...

2024-04-04 11:12:55 ET More on Health Care Select Sector SPDR: XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli...